NOT KNOWN FACTUAL STATEMENTS ABOUT MILD COGNITIVE IMPAIRMENT TEST

For the reason that people who carry the APOE e4 gene variant surface to have a increased risk of significant problems, the FDA suggests remaining tested for your gene variant before beginning treatment with lecanemab or donanemab.After we evaluate the final results of your dementia evaluation, We are going to give you a proof for virtually any mod